Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine.

Kringel D, Lötsch J.

Clin Chim Acta. 2016 Dec 1;463:32-38. doi: 10.1016/j.cca.2016.10.009. Epub 2016 Oct 8.

2.

Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.

Shi X, Walter NA, Harkness JH, Neve KA, Williams RW, Lu L, Belknap JK, Eshleman AJ, Phillips TJ, Janowsky A.

PLoS One. 2016 Mar 31;11(3):e0152581. doi: 10.1371/journal.pone.0152581. eCollection 2016.

3.

Opioids for chronic pain: a knowledge assessment of nonpain specialty providers.

Pearson AC, Eldrige JS, Moeschler SM, Hooten WM.

J Pain Res. 2016 Mar 10;9:129-35. doi: 10.2147/JPR.S98273. eCollection 2016.

4.

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL.

Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.

5.

Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S.

BMC Syst Biol. 2015 Jun 5;9:25. doi: 10.1186/s12918-015-0167-x.

6.

A psycho-genetic study of hedonic responsiveness in relation to "food addiction".

Davis C, Loxton NJ.

Nutrients. 2014 Oct 16;6(10):4338-53. doi: 10.3390/nu6104338.

7.

Advances in genetic studies of substance abuse in China.

Sun Y, Meng S, Li J, Shi J, Lu L.

Shanghai Arch Psychiatry. 2013 Aug;25(4):199-211. doi: 10.3969/j.issn.1002-0829.2013.04.002. Review.

8.

Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).

Knapman A, Connor M.

Br J Pharmacol. 2015 Jan;172(2):349-63. doi: 10.1111/bph.12644. Epub 2014 Jul 1. Review.

9.

Pharmacogenetics of OPRM1.

Crist RC, Berrettini WH.

Pharmacol Biochem Behav. 2014 Aug;123:25-33. doi: 10.1016/j.pbb.2013.10.018. Epub 2013 Nov 5. Review.

10.

Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake.

Eastwood EC, Phillips TJ.

Genes Brain Behav. 2014 Feb;13(2):226-35. doi: 10.1111/gbb.12100. Epub 2013 Nov 18.

11.

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura E, Govoni S, Racchi M, Carossa V, Ranzani GN, Allegri M, van Schaik RH.

J Pain Res. 2013 May 1;6:331-53. doi: 10.2147/JPR.S42040. Print 2013.

12.

NCK2 is significantly associated with opiates addiction in African-origin men.

Liu Z, Guo X, Jiang Y, Zhang H.

ScientificWorldJournal. 2013;2013:748979. doi: 10.1155/2013/748979. Epub 2013 Feb 28.

13.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

14.

Is the pain-reducing effect of opioid medication reliable? A psychophysical study of morphine and pentazocine analgesia.

King CD, Goodin B, Glover TL, Riley JL, Hou W, Staud R, Fillingim RB.

Pain. 2013 Mar;154(3):476-83. doi: 10.1016/j.pain.2012.12.009. Epub 2012 Dec 28.

15.

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER.

J Clin Invest. 2012 Oct;122(10):3387-93. doi: 10.1172/JCI60390. Epub 2012 Oct 1. Review.

16.

Close association between A118G single nucleotide polymorphism and opioid, alcohol, and nicotine dependence.

Kapoor S.

Psychol Res Behav Manag. 2012;5:47-9. doi: 10.2147/PRBM.S31992. Epub 2012 May 9. No abstract available.

17.

The genetics of the opioid system and specific drug addictions.

Levran O, Yuferov V, Kreek MJ.

Hum Genet. 2012 Jun;131(6):823-42. doi: 10.1007/s00439-012-1172-4. Epub 2012 May 1. Review.

18.

Common and specific liability to addiction: approaches to association studies of opioid addiction.

Nielsen DA, Kreek MJ.

Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S33-41. doi: 10.1016/j.drugalcdep.2012.03.026. Epub 2012 Apr 27. Review.

19.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

20.

Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Al-Hasani R, Bruchas MR.

Anesthesiology. 2011 Dec;115(6):1363-81. doi: 10.1097/ALN.0b013e318238bba6. Review.

Supplemental Content

Support Center